期刊文献+

TNF-α在银屑病的发病及治疗中的研究进展 被引量:5

Research advances of TNF-α in the mechanisms and treatment of psoriasis
下载PDF
导出
摘要 近年来的研究显示,肿瘤坏死因子-α(TNF-α)在宿主防御和致炎过程中发挥了重要作用。在银屑病患者的皮损区和循环血液中发现TNF-α的过分表达,提示TNF-α在银屑病中起着至关重要的作用。临床试验已经证明抑制TNF-α活性能有效对抗银屑病。该文主要总结TNF-α与银屑病的关系、抑制TNF-α的生物制剂以及这些制剂的临床和免疫效果。 Numerous recent investigations have pointed out a key role of the tumor necrosis factor-α (TNF-α) in host defense and inflammatory processes. TNF-α overexpression has been found in lesional skin and in the circulation of psoriatic patients, and it was suggested that TNF-α is crucial in psoriasis. Several approaches to inhibiting TNF-α activity have been developed. Clinical trials have demonstrated significant antipsoriatic effects. This article reviews the relationship of TNF-α and psoriasis, the biological preparations to inhibit TNF-α activity, and their clinical and immunological effects in psoriasis.
作者 刘骅 金涌
出处 《安徽医药》 CAS 2006年第5期321-323,共3页 Anhui Medical and Pharmaceutical Journal
基金 安徽省教育厅自然科学研究项目:2004kj196安 徽医科大学博士基金课题
关键词 细胞因子 TNF-Α 银屑病 免疫治疗 cytokines TNF-α psoriasis immunotherapy
  • 相关文献

参考文献17

  • 1Asadullah K,Volk HD,Sterry W.Novel immunotherapies for psoriasis[J].Trends Immunol,2002,23(1):47-53.
  • 2Idriss HT,Naismith JH.TNF alpha and the TNF receptor superfamily:structure-function relationship[S].Microsc Res Tech,2000,50(3):184-195.
  • 3Serwin AB,Flisiak I,Chodynicka B et al.The role of tumor necrosis factor alpha receptors(TNF-alpha) in psoriasis and other skin disorders[J].Wiad Lek,2004,57(11-12):686-90.
  • 4龙福泉,李学平.肿瘤坏死因子α多态性与银屑病[J].国外医学(遗传学分册),2004,27(5):318-321. 被引量:2
  • 5Schopf RE,Aust H,Knop J.Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha,infliximab[J].J Am Acad Dermatol,2002,46(6):886-91.
  • 6Saini R,Tutrone WD,Weinberg JM et al.Advances in therapy for psoriasis:an overview of inflixmab,enanercept,efalizumab,alefacept,adalimumab,tazarotene,and pinmecrolimus[J].Curr pharm,2005,11 (2):273-80.
  • 7Oh CJ.Das KM.Gottlieb AB.Treatment with anti-tumor necrosis factor alpha(TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions[J].J Am Acad Dermatol,2000,42(5 Pt 1):829-30.
  • 8Chaudhari U,Romano P,Mulcahy LD.et al.Efficacy and safety of infliximab monotherapy for plaque-type psoriasis:a randomised trial[J].Lancet,2001,357(9271):1842-7.
  • 9Ogilvie AL,Antoni C,Dehant C,et al.Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate[J].Br J Dermatol,2001,144(3):587-9.
  • 10Elewski BE.Infliximab for the treatment of severe pustular psoriasis[J].J Am Acad Dermatol,2002,47(5):796-7.

二级参考文献20

  • 1Reich K, Westphal G, Schulz T, et al. Combined analysis of polymorphisms of the tumor necrosis factor -alpha and interleukin-10 promotor regions and polymorphic reuokiotic metabolizing enzymes in psoriasis. J Invest Dermatol, 1999, 113(2): 214-220.
  • 2Reich K, Mossner R, Konig IR, et al. Promotor polymorphisms of the genes encoding tumor necrosis factor- alpha and interleukin-1 beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol, 200
  • 3Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-238A promoter polymorphism. J Invest Dermatol,2000, 114(6): 1180-1183.
  • 4Nishibu A, Oyama N , Nakamura K, et al. Lack of association of TNF-238A and -308A in Japanese patients with psoriasis vulgaris,psoriatic arthritis and generalized pustular psoriasis. J Dermatol Sci,2002, 29(3): 181-184.
  • 5Stuber F, Udalova IA, Book M, et al. 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promotor. J Inflamm, 1996, 46: 42-50.
  • 6Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol, 1998, 113(3): 401-406.
  • 7Brinkman BM, Huizingga TW. Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of disease. Br J Rheumatol, 1997, 36: 516-521.
  • 8Hohler T, Grossmann S, Stadmann-Bellinghausen B, et al. Differential association of polymorphisms in the TNFalpha region with psoriatic arthriatis but not psoriasis. Ann Rheum Dis, 2002, 61(3): 213-218.
  • 9Alheresh AM, Proctor J, Jones SM, et al. Tumor necrosis factor- alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford), 2002,41(5): 525-530.
  • 10Gonzalez S, Brautbar C, Martinez-Borra J, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish poptlation. Hum Immunol, 2001, 62(6): 632-638.

共引文献1

同被引文献54

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部